C-Reactive Protein Testing Market

Global C-Reactive Protein Testing Market by Assay Types (Immunoturbidimetric, ELISA, Turbidometric, and Others), Applications (Cardiovascular disease, Cancer, Diabetes, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, and Others), End-uses (Clinics, Hospitals, Diagnostic Labs, and Others), and Regions (North America, Asia-Pacific, Latin America, Middle East and Africa, and Europe) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-1115
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 2
  • No. Of Pages: 123
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global C-reactive protein testing market was valued at USD 1.8 million in 2019 and is expected to reach USD 1.93 billion by 2028, expanding at a CAGR of 1.8% during the forecast period, 2021 – 2028. The growth of the market is attributed to increasing number of diseases such as rheumatoid arthritis, inflammatory bowel disease, cancer, and cardiovascular diseases.

C-reactive protein (CRP) is a substance produced by the liver, due to inflammation. C-reactive protein is known as High-Sensitivity C-reactive protein (HS-CRP) and Ultra-Sensitive C-reactive protein (US-CRP). A high level of CRP in blood causes inflammation in the body, which results in small infections to severe diseases.

C-reactive protein is measured in milligram of CRP per liter of blood (mg/L).

Reading

Risk

Less than 1 mg/L

Low risk of cardiovascular disease

Between 1 and 2.9 mg/L

Intermediate risk

Between 3 and 9.9 mg/L

High risk


High reading of above 10 mg/L indicates severe diseases including:

  • Bone infection
  • IBD
  • Cancer
  • Lupus, connective tissue disease, or other autoimmune diseases
  • Tuberculosis
  • Pneumonia
  • Autoimmune arthritis flare-up
  • Other diseases

Market Trends, Drivers, Restraints, Opportunity

  • Increasing number of diseases such as rheumatoid arthritis, inflammatory bowel disease, cancers, and cardiovascular diseases, is a major driving force for the market.
  • Technological advancement in diagnostics and increasing investments for diagnostics research are expected to drive the market during the forecast period.
  • Increasing initiatives by international bodies for the prevention and treatment of chronic disorders is significantly accelerating the growth of the C-reactive protein testing market during the forecast period.
  • Presence of bacterial and viral infection is diagnosed by C-reactive protein testing, which helps drive the market.
  • Lack of public awareness regarding CRP (C-reactive protein) testing restrains the market growth.
  • Other blood tests such as erythrocyte sedimentation rate (ESR) give accurate results when compared with the C-reactive protein testing market, which restrains the market growth.

Scope of the Report

The report on the global C-reactive protein testing market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Overall Period

2018–2028

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Trends, and Revenue Forecast

 

Global C-reactive Protein Testing Market Segment Insights

Global C-reactive Protein Testing Market Taxonomy

Based on assay types, the market is divided into immunoturbidimetric, ELISA, Turbidometric, and others. The immunoturbidimetric assay segment has a considerable market share and this trend is expected to continue during the forecast period. Availability of highly sensitive automated immunoturbidimetric assays and increased exploratory activities in immunoturbidimetric assays are expected to play an important role in the field of immunoturbidimetric assays.

On the basis of applications, the market is divided into cardiovascular disease, cancer, diabetes, rheumatoid arthritis, inflammatory bowel disease, endometriosis, lupus, and others. The cardiovascular disease segment has a considerable market share and this trend is expected to continue during the forecast period. Factors such as rising incidence of cardiovascular diseases, rapid growth of the elderly population, and increasing use of CRP testing to determine the risk of heart attack or stroke are anticipated to play an important role in the field of cardiovascular diseases.

In terms of end-uses, the market is segregated into clinics, hospitals, diagnostic labs, and others. The clinics segment has a considerable market share and this trend is expected to continue during the forecast period. Testing in primary health care institutions, availability of testing, and increasing need to improve the diagnosis and treatment of chronic inflammatory diseases in primary and secondary health care institutions are expected to play an important role in the clinics segment.

Based on regions, the market is divided into North America, Asia Pacific, Latin America, Middle East and Africa, and Europe. Asia Pacific has a significant market share and this trend is expected to continue during the forecast period. The market in Asia Pacific is majorly driven by the development of advanced CRP testing, development of modern medical facilities, and lifestyle changes, which led to an increase in the prevalence of cardiovascular diseases.

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. C-Reactive Protein Testing Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. C-Reactive Protein Testing Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. C-Reactive Protein Testing Market - Supply Chain
  4.5. Global C-Reactive Protein Testing Market Forecast
     4.5.1. C-Reactive Protein Testing Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. C-Reactive Protein Testing Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. C-Reactive Protein Testing Market Absolute $ Opportunity
5. Global C-Reactive Protein Testing Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. C-Reactive Protein Testing Market Size and Volume Forecast by Types
     5.3.1. Immunoturbidimetric
     5.3.2. ELISA
     5.3.3. Turbidometric
     5.3.4. Others
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global C-Reactive Protein Testing Market Analysis and Forecast by Applications
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Applications
     6.2.2. Y-o-Y Growth Projections by Applications
  6.3. C-Reactive Protein Testing Market Size and Volume Forecast by Applications
     6.3.1. Cardiovascular disease
     6.3.2. Cancer
     6.3.3. Diabetes
     6.3.4. Rheumatoid Arthritis
     6.3.5. Inflammatory Bowel Disease
     6.3.6. Endometriosis
     6.3.7. Lupus
     6.3.8. Other
  6.4. Absolute $ Opportunity Assessment by Applications
  6.5. Market Attractiveness/Growth Potential Analysis by Applications
7. Global C-Reactive Protein Testing Market Analysis and Forecast by End Users
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by End Users
     7.2.2. Y-o-Y Growth Projections by End Users
  7.3. C-Reactive Protein Testing Market Size and Volume Forecast by End Users
     7.3.1. Clinics
     7.3.2. Hospitals
     7.3.3. Diagnostic Labs
     7.3.4. Others
  7.4. Absolute $ Opportunity Assessment by End Users
  7.5. Market Attractiveness/Growth Potential Analysis by End Users
8. Global C-Reactive Protein Testing Market Analysis and Forecast by Region
  8.1. Market Trends
  8.2. Introduction
     8.2.1. Basis Point Share (BPS) Analysis by Region
     8.2.2. Y-o-Y Growth Projections by Region
  8.3. C-Reactive Protein Testing Market Size and Volume Forecast by Region
     8.3.1. North America
     8.3.2. Latin America
     8.3.3. Europe
     8.3.4. Asia Pacific
     8.3.5. Middle East and Africa (MEA)
  8.4. Absolute $ Opportunity Assessment by Region
  8.5. Market Attractiveness/Growth Potential Analysis by Region
  8.6. Global C-Reactive Protein Testing Demand Share Forecast, 2019-2026
9. North America C-Reactive Protein Testing Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
  9.2. North America C-Reactive Protein Testing Market Size and Volume Forecast by Country
     9.2.1. U.S.
     9.2.2. Canada
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. North America C-Reactive Protein Testing Market Size and Volume Forecast by Types
     9.4.1. Immunoturbidimetric
     9.4.2. ELISA
     9.4.3. Turbidometric
     9.4.4. Others
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. North America C-Reactive Protein Testing Market Size and Volume Forecast by Applications
     9.7.1. Cardiovascular disease
     9.7.2. Cancer
     9.7.3. Diabetes
     9.7.4. Rheumatoid Arthritis
     9.7.5. Inflammatory Bowel Disease
     9.7.6. Endometriosis
     9.7.7. Lupus
     9.7.8. Other
  9.8. Basis Point Share (BPS) Analysis by Applications
  9.9. Y-o-Y Growth Projections by Applications
  9.10. North America C-Reactive Protein Testing Market Size and Volume Forecast by End Users
     9.10.1. Clinics
     9.10.2. Hospitals
     9.10.3. Diagnostic Labs
     9.10.4. Others
  9.11. Basis Point Share (BPS) Analysis by End Users
  9.12. Y-o-Y Growth Projections by End Users
  9.13. Market Attractiveness/Growth Potential Analysis
     9.13.1. By Country
     9.13.2. By Product Type
     9.13.3. By Application
  9.14. North America C-Reactive Protein Testing Demand Share Forecast, 2019-2026
10. Latin America C-Reactive Protein Testing Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Latin America Average Pricing Analysis
  10.2. Latin America C-Reactive Protein Testing Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
  10.4. Latin America C-Reactive Protein Testing Market Size and Volume Forecast by Types
     10.4.1. Immunoturbidimetric
     10.4.2. ELISA
     10.4.3. Turbidometric
     10.4.4. Others
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Latin America C-Reactive Protein Testing Market Size and Volume Forecast by Applications
     10.7.1. Cardiovascular disease
     10.7.2. Cancer
     10.7.3. Diabetes
     10.7.4. Rheumatoid Arthritis
     10.7.5. Inflammatory Bowel Disease
     10.7.6. Endometriosis
     10.7.7. Lupus
     10.7.8. Other
  10.8. Basis Point Share (BPS) Analysis by Applications
  10.9. Y-o-Y Growth Projections by Applications
  10.10. Latin America C-Reactive Protein Testing Market Size and Volume Forecast by End Users
     10.10.1. Clinics
     10.10.2. Hospitals
     10.10.3. Diagnostic Labs
     10.10.4. Others
  10.11. Basis Point Share (BPS) Analysis by End Users
  10.12. Y-o-Y Growth Projections by End Users
  10.13. Market Attractiveness/Growth Potential Analysis
     10.13.1. By Country
     10.13.2. By Product Type
     10.13.3. By Application
  10.14. Latin America C-Reactive Protein Testing Demand Share Forecast, 2019-2026
11. Europe C-Reactive Protein Testing Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Europe Average Pricing Analysis
  11.2. Europe C-Reactive Protein Testing Market Size and Volume Forecast by Country
     11.2.1. Germany
     11.2.2. France
     11.2.3. Italy
     11.2.4. U.K.
     11.2.5. Spain
     11.2.6. Russia
     11.2.7. Rest of Europe
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Europe C-Reactive Protein Testing Market Size and Volume Forecast by Types
     11.4.1. Immunoturbidimetric
     11.4.2. ELISA
     11.4.3. Turbidometric
     11.4.4. Others
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Europe C-Reactive Protein Testing Market Size and Volume Forecast by Applications
     11.7.1. Cardiovascular disease
     11.7.2. Cancer
     11.7.3. Diabetes
     11.7.4. Rheumatoid Arthritis
     11.7.5. Inflammatory Bowel Disease
     11.7.6. Endometriosis
     11.7.7. Lupus
     11.7.8. Other
  11.8. Basis Point Share (BPS) Analysis by Applications
  11.9. Y-o-Y Growth Projections by Applications
  11.10. Europe C-Reactive Protein Testing Market Size and Volume Forecast by End Users
     11.10.1. Clinics
     11.10.2. Hospitals
     11.10.3. Diagnostic Labs
     11.10.4. Others
  11.11. Basis Point Share (BPS) Analysis by End Users
  11.12. Y-o-Y Growth Projections by End Users
  11.13. Market Attractiveness/Growth Potential Analysis
     11.13.1. By Country
     11.13.2. By Product Type
     11.13.3. By Application
  11.14. Europe C-Reactive Protein Testing Demand Share Forecast, 2019-2026
12. Asia Pacific C-Reactive Protein Testing Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Asia Pacific Average Pricing Analysis
  12.2. Asia Pacific C-Reactive Protein Testing Market Size and Volume Forecast by Country
     12.2.1. China
     12.2.2. Japan
     12.2.3. South Korea
     12.2.4. India
     12.2.5. Australia
     12.2.6. Rest of Asia Pacific (APAC)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Asia Pacific C-Reactive Protein Testing Market Size and Volume Forecast by Types
     12.4.1. Immunoturbidimetric
     12.4.2. ELISA
     12.4.3. Turbidometric
     12.4.4. Others
  12.5. Basis Point Share (BPS) Analysis by Types
  12.6. Y-o-Y Growth Projections by Types
  12.7. Asia Pacific C-Reactive Protein Testing Market Size and Volume Forecast by Applications
     12.7.1. Cardiovascular disease
     12.7.2. Cancer
     12.7.3. Diabetes
     12.7.4. Rheumatoid Arthritis
     12.7.5. Inflammatory Bowel Disease
     12.7.6. Endometriosis
     12.7.7. Lupus
     12.7.8. Other
  12.8. Basis Point Share (BPS) Analysis by Applications
  12.9. Y-o-Y Growth Projections by Applications
  12.10. Asia Pacific C-Reactive Protein Testing Market Size and Volume Forecast by End Users
     12.10.1. Clinics
     12.10.2. Hospitals
     12.10.3. Diagnostic Labs
     12.10.4. Others
  12.11. Basis Point Share (BPS) Analysis by End Users
  12.12. Y-o-Y Growth Projections by End Users
  12.13. Market Attractiveness/Growth Potential Analysis
     12.13.1. By Country
     12.13.2. By Product Type
     12.13.3. By Application
  12.14. Asia Pacific C-Reactive Protein Testing Demand Share Forecast, 2019-2026
13. Middle East & Africa C-Reactive Protein Testing Market Analysis and Forecast
  13.1. Introduction
     13.1.1. Basis Point Share (BPS) Analysis by Country
     13.1.2. Y-o-Y Growth Projections by Country
     13.1.3. Middle East & Africa Average Pricing Analysis
  13.2. Middle East & Africa C-Reactive Protein Testing Market Size and Volume Forecast by Country
     13.2.1. Saudi Arabia
     13.2.2. South Africa
     13.2.3. UAE
     13.2.4. Rest of Middle East & Africa (MEA)
  13.3. Absolute $ Opportunity Assessment by Country
  13.4. Middle East & Africa C-Reactive Protein Testing Market Size and Volume Forecast by Types
     13.4.1. Immunoturbidimetric
     13.4.2. ELISA
     13.4.3. Turbidometric
     13.4.4. Others
  13.5. Basis Point Share (BPS) Analysis by Types
  13.6. Y-o-Y Growth Projections by Types
  13.7. Middle East & Africa C-Reactive Protein Testing Market Size and Volume Forecast by Applications
     13.7.1. Cardiovascular disease
     13.7.2. Cancer
     13.7.3. Diabetes
     13.7.4. Rheumatoid Arthritis
     13.7.5. Inflammatory Bowel Disease
     13.7.6. Endometriosis
     13.7.7. Lupus
     13.7.8. Other
  13.8. Basis Point Share (BPS) Analysis by Applications
  13.9. Y-o-Y Growth Projections by Applications
  13.10. Middle East & Africa C-Reactive Protein Testing Market Size and Volume Forecast by End Users
     13.10.1. Clinics
     13.10.2. Hospitals
     13.10.3. Diagnostic Labs
     13.10.4. Others
  13.11. Basis Point Share (BPS) Analysis by End Users
  13.12. Y-o-Y Growth Projections by End Users
  13.13. Market Attractiveness/Growth Potential Analysis
     13.13.1. By Country
     13.13.2. By Product Type
     13.13.3. By Application
  13.14. Middle East & Africa C-Reactive Protein Testing Demand Share Forecast, 2019-2026
14. Competition Landscape
  14.1. Global C-Reactive Protein Testing Market: Market Share Analysis
  14.2. C-Reactive Protein Testing Distributors and Customers
  14.3. C-Reactive Protein Testing Market: Competitive Dashboard
  14.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     14.4.1. Hoffmann-La Roche Ltd.
     14.4.2. Danaher
     14.4.3. Quest Diagnostics Incorporated
     14.4.4. Siemens
     14.4.5. Abbott Laboratories
     14.4.6. Laboratory Corporation of America Holdings
     14.4.7. Merck KGaA
     14.4.8. Abaxis Inc.
Segments Covered in the Report
The global C-reactive protein testing market has been segmented on the basis of:

Assay Types
  • Immunoturbidimetric
  • ELISA
  • Turbidometric
  • Others
Applications
  • Cardiovascular disease
  • Cancer
  • Diabetes
  • Rheumatoid Arthritis
  • Inflammatory Bowel Disease
  • Endometriosis
  • Lupus
  • Others
End-uses
  • Clinics
  • Hospitals
  • Diagnostic Labs
  • Others
Regions
  • North America
  • Asia-Pacific
  • Middle East and Africa
  • Latin America
  • Europe
Key Player
  • Hoffmann-La Roche Ltd.
  • Danaher
  • Quest Diagnostics Incorporated
  • Siemens
  • Abbott Laboratories
  • Laboratory Corporation of America Holdings
  • Merck KGaA
  • Abaxis Inc.
  • Ortho Clinical Diagnostics
  • Getein Biotech Inc.
  • HORIBA Ltd.
  • Randox Laboratories Ltd.
  • BODITECH MED INC.
  • Aidianm

In the competitive environment, companies are adopting different strategies to capture the market and offer tough competition to their competitors. Companies focus on R&D, product launches, product approvals, patents, merger & acquisitions, partnerships, and collaborations. These strategies help in capturing large market share in the long-run. Some of the key players in the market are: Hoffmann-La Roche Ltd., Danaher, Quest Diagnostics Incorporated, Siemens, Abbott Laboratories, Laboratory Corporation of America Holdings, Merck KGaA, Abaxis, Inc., Ortho Clinical Diagnostics, Getein Biotech, Inc., HORIBA, Ltd., Randox Laboratories Ltd., BODITECH MED INC., and Aidianm.

Buy Report